If B-OM P2 delivers strong topline results sounds like an agreement could be "inked" very quickly. Leo left me with the impression that, for the most part, all that would remain is to dot the iiiiis and cross the ttttts.
I have great confidence that IPIX will have an agreement/partnership before year's end.
Message in reply to:
Validation of BP interest;
"Formal collaboration with pharmaceutical companies that have expressed an interest in partnering Brilacidin-OM may well assist further with expediting the drug candidate’s development timetable. Some of these partnering conversations have matured to the point of potentially structuring mutually beneficial licensing agreements, pending the final Phase 2 study results."
Market Data 
Markets 
AI
